FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Zoledronic Acid Injection
Status: Discontinuation
»Therapeutic Categories: Musculoskeletal; Oncology

Teva Pharmaceuticals (New 05/01/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
0.8 mg/mL, 4 mg 5 mL/Vial (NDC 45963-440-55) 05/01/2019 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English